KNApSAcK Metabolite C00018015
Metabolite
KNApSAcK Entry
| id | C00018015 |
|---|---|
| Name | HE 69 / Bredinin / NSC 289637 / Mizoribine / beta-Bredinin |
| CAS RN | 50924-49-7 |
| Standard InChI | InChI=1S/C9H13N3O6/c10-7(16)4-8(17)12(2-11-4)9-6(15)5(14)3(1-13)18-9/h2-3,5-6,9,13-15,17H,1H2,(H2,10,16)/t3-,5-,6-,9-/m1/s1 |
| Standard InChI (Main Layer) | InChI=1S/C9H13N3O6/c10-7(16)4-8(17)12(2-11-4)9-6(15)5(14)3(1-13)18-9/h2-3,5-6,9,13-15,17H,1H2,(H2,10,16) |
Cluster
| Phytochemical cluster | |
|---|---|
| KCF-S cluster | No. 6302 |
Link
ChEMBL
| By standard InChI | CHEMBL245019 |
|---|---|
| By standard InChI Main Layer | CHEMBL165000 CHEMBL245019 CHEMBL607652 CHEMBL1512470 |
KEGG
| By LinkDB |
|---|
CTD
| By CAS RN | C010052 |
|---|
Species
Summary
Plant class
| class name | count |
|---|
Family
| family name | count |
|---|---|
| Aspergillaceae | 1 |
List (1)
* NCBI
| KNApSAcK organism | *ID | *family | *plant class | *kingdom |
|---|---|---|---|---|
| Eupenicillium brefeldianum M-2166 | 28577 | Aspergillaceae | Fungi |
Human Protein / Gene in interaction
17 ChEMBL Protein in interactions
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL1512470 |
CHEMBL1741321
(1)
|
1 / 0 |
| Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL245019 |
CHEMBL1613842
(1)
|
4 / 2 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL245019 |
CHEMBL1794499
(1)
|
2 / 0 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL245019 |
CHEMBL1614076
(1)
|
1 / 1 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL245019 |
CHEMBL1738600
(1)
|
0 / 0 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL1512470 |
CHEMBL1614281
(1)
CHEMBL1614361
(1)
|
3 / 2 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL1512470 |
CHEMBL1741325
(1)
|
0 / 1 |
| P54132 | Bloom syndrome protein | Enzyme | CHEMBL245019 |
CHEMBL1614522
(1)
CHEMBL1614067
(1)
|
1 / 2 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL245019 |
CHEMBL1614458
(1)
|
0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL245019 |
CHEMBL1738606
(2)
|
0 / 0 |
| P42858 | Huntingtin | Unclassified protein | CHEMBL245019 |
CHEMBL1613918
(1)
|
1 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL1512470 |
CHEMBL1741322
(1)
|
0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL1512470 |
CHEMBL1741323
(1)
|
1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1512470 |
CHEMBL1741324
(1)
|
0 / 1 |
| Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL245019 |
CHEMBL1794483
(1)
|
0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL245019 |
CHEMBL1613914
(1)
|
0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL245019 |
CHEMBL1738442
(2)
|
0 / 0 |
Related Disease
Diseases related to proteins in ChEMBL interactions
OMIM (14)
| OMIM | preferred title | UniProt |
|---|---|---|
| #210900 | Bloom syndrome; blm |
P54132
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #143100 | Huntington disease; hd |
P42858
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
KEGG DISEASE (10)
| KEGG | disease name | UniProt |
|---|---|---|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00059 | Huntington's disease (HD) |
P42858
(related)
|
| H00094 | DNA repair defects |
P54132
(related)
|
| H00296 | Defects in RecQ helicases |
P54132
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
Diseases related to CTD interactions
4 disease from interactions of metabolites
| MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
|---|---|---|---|---|---|
| D009374 | C010052 | Neoplasms, Experimental |
therapeutic
|
2239571
|
|
| D009393 | C010052 | Nephritis |
therapeutic
|
3656695
|
|
| D009404 | C010052 | Nephrotic Syndrome |
therapeutic
|
9323293
|
|
| D011507 | C010052 | Proteinuria |
therapeutic
|
8919236
20502051 |